Moderna launches late-stage trial of mRNA bird flu vaccine

The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions

India chairs first BRICS Health Working Group meet

Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports

Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26